BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1048 related articles for article (PubMed ID: 18420966)

  • 21. Role of platelet-derived growth factor/platelet-derived growth factor receptor axis in the trafficking of circulating fibrocytes in pulmonary fibrosis.
    Aono Y; Kishi M; Yokota Y; Azuma M; Kinoshita K; Takezaki A; Sato S; Kawano H; Kishi J; Goto H; Uehara H; Izumi K; Nishioka Y
    Am J Respir Cell Mol Biol; 2014 Dec; 51(6):793-801. PubMed ID: 24885373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma.
    Kubo T; Piperdi S; Rosenblum J; Antonescu CR; Chen W; Kim HS; Huvos AG; Sowers R; Meyers PA; Healey JH; Gorlick R
    Cancer; 2008 May; 112(10):2119-29. PubMed ID: 18338812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of imatinib on PDGF-induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cells.
    Li L; Blumenthal DK; Masaki T; Terry CM; Cheung AK
    J Cell Biochem; 2006 Dec; 99(6):1553-63. PubMed ID: 16817200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension.
    Zhuang W; Lian G; Huang B; Du A; Gong J; Xiao G; Xu C; Wang H; Xie L
    Mol Cell Biochem; 2019 May; 455(1-2):169-183. PubMed ID: 30511343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COP9 signalosome subunit 6 mediates PDGF -induced pulmonary arterial smooth muscle cells proliferation.
    Zhu Y; Li F; Shi W; Zhai C; Wang J; Yan X; Wang Q; Zhang Q; Yang L; Gao L; Li M
    Exp Cell Res; 2018 Oct; 371(2):379-388. PubMed ID: 30180991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PDGF Promotes the Warburg Effect in Pulmonary Arterial Smooth Muscle Cells via Activation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway.
    Xiao Y; Peng H; Hong C; Chen Z; Deng X; Wang A; Yang F; Yang L; Chen C; Qin X
    Cell Physiol Biochem; 2017; 42(4):1603-1613. PubMed ID: 28738389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension.
    Nakamura K; Sakaguchi M; Matsubara H; Akagi S; Sarashina T; Ejiri K; Akazawa K; Kondo M; Nakagawa K; Yoshida M; Miyoshi T; Ogo T; Oto T; Toyooka S; Higashimoto Y; Fukami K; Ito H
    PLoS One; 2018; 13(9):e0203046. PubMed ID: 30180189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PDGF-C and -D induced proliferation/migration of human RPE is abolished by inflammatory cytokines.
    Li R; Maminishkis A; Wang FE; Miller SS
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5722-32. PubMed ID: 18055825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imatinib mesylate has the potential to exert its efficacy by down-regulating the plasma concentration of platelet-derived growth factor in patients with pulmonary arterial hypertension.
    Hatano M; Yao A; Shiga T; Kinugawa K; Hirata Y; Nagai R
    Int Heart J; 2010 Jul; 51(4):272-6. PubMed ID: 20716845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB.
    Aoki M; Nabeshima K; Koga K; Hamasaki M; Suzumiya J; Tamura K; Iwasaki H
    Lab Invest; 2007 Aug; 87(8):767-79. PubMed ID: 17558420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imatinib mesylate inhibits the proliferation-stimulating effect of human lung cancer-associated stromal fibroblasts on lung cancer cells.
    Kinoshita K; Nakagawa K; Hamada J; Hida Y; Tada M; Kondo S; Moriuchi T
    Int J Oncol; 2010 Oct; 37(4):869-77. PubMed ID: 20811709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor.
    Abouantoun TJ; MacDonald TJ
    Mol Cancer Ther; 2009 May; 8(5):1137-47. PubMed ID: 19417143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PDGF-dependent β-catenin activation is associated with abnormal pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension.
    Takahashi J; Orcholski M; Yuan K; de Jesus Perez V
    FEBS Lett; 2016 Jan; 590(1):101-9. PubMed ID: 26787464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The novel roles of YULINK in the migration, proliferation and glycolysis of pulmonary arterial smooth muscle cells: implications for pulmonary arterial hypertension.
    Wu YC; Wang WT; Yang MC; Su YT; Yeh JL; Hsu JH; Wu JR
    Biol Res; 2023 Dec; 56(1):66. PubMed ID: 38057829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycogen synthase kinase 3beta contributes to proliferation of arterial smooth muscle cells in pulmonary hypertension.
    Sklepkiewicz P; Schermuly RT; Tian X; Ghofrani HA; Weissmann N; Sedding D; Kashour T; Seeger W; Grimminger F; Pullamsetti SS
    PLoS One; 2011 Apr; 6(4):e18883. PubMed ID: 21533110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
    Zymek P; Bujak M; Chatila K; Cieslak A; Thakker G; Entman ML; Frangogiannis NG
    J Am Coll Cardiol; 2006 Dec; 48(11):2315-23. PubMed ID: 17161265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression.
    Ciuclan L; Hussey MJ; Burton V; Good R; Duggan N; Beach S; Jones P; Fox R; Clay I; Bonneau O; Konstantinova I; Pearce A; Rowlands DJ; Jarai G; Westwick J; MacLean MR; Thomas M
    Am J Respir Crit Care Med; 2013 Jan; 187(1):78-89. PubMed ID: 23087024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-derived growth factor (PDGF) induces pulmonary vascular remodeling through 15-LO/15-HETE pathway under hypoxic condition.
    Zhang L; Ma J; Shen T; Wang S; Ma C; Liu Y; Ran Y; Wang L; Liu L; Zhu D
    Cell Signal; 2012 Oct; 24(10):1931-9. PubMed ID: 22735810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-derived growth factor receptor transactivation mediates the trophic effects of angiotensin II in vivo.
    Kelly DJ; Cox AJ; Gow RM; Zhang Y; Kemp BE; Gilbert RE
    Hypertension; 2004 Aug; 44(2):195-202. PubMed ID: 15197170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.